Hinge-region Cys-to-Ser mutation enables homogeneous DAR6 anti-c-Met biparatopic ADCs with tolerable O-glycosylation
Deyong Song, Zhenduo Shen, Xiaolin Zhu, Haifeng Zhao, Yingdi Wang, Junmei Zhang, Rui Li, Hongguang Xu, Zengjin Cheng, Xiaoju Ma, Haixia Lin, Changlin Dou, Min Xiao · 2026
Read Hinge-region Cys-to-Ser mutation enables homogeneous DAR6 anti-c-Met biparatopic ADCs with tolerable O-glycosylation by Deyong Song, Zhenduo Shen, Xiaolin Zhu, Haifeng Zhao, Yingdi Wang, Junmei Zhang, Rui Li, Hongguang Xu, Zengjin Cheng, Xiaoju Ma, Haixia Lin, Changlin Dou, Min Xiao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13628133.txt.
Description
Song and colleagues engineered in 2026 a tweak to antibody-drug conjugates that fixes how many drug units each antibody carries. Conjugates with a uniform drug-to-antibody ratio act more alike in the body. Making a uniform ratio of six drugs per antibody, called DAR6, has been hard. The team mutated one cysteine, a sulfur-bearing amino acid, in the antibody hinge region of a dual-target anti-c-Met antibody.
During testing, extra mass species appeared, traced to mucin-type sugar chains attached at a hinge serine. That sugar modification, called O-glycosylation, also appeared in other antibodies with similar hinge mutations. It was therefore not a quirk of one antibody scaffold. Cutting the open sites made the joining step yield uniform DAR6 products every time. The authors present hinge engineering as a flexible route to such conjugates.
Catalog record
| CREATOR | Deyong Song, Zhenduo Shen, Xiaolin Zhu, Haifeng Zhao, Yingdi Wang, Junmei Zhang, Rui Li, Hongguang Xu, Zengjin Cheng, Xiaoju Ma, Haixia Lin, Changlin Dou, Min Xiao |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |